Veracyte Inc (VCYT.OQ)
16 Feb 2018
Mon, Jan 8 2018
* VERACYTE ANNOUNCES STRATEGIC REALIGNMENT AND NEW APPOINTMENTS TO ADVANCE COMMERCIAL GROWTH
* Q3 earnings per share view $-0.23 -- Thomson Reuters I/B/E/S
BRIEF-Veracyte announces release of 2018 preliminary reimbursement rate for Afirma Genomic Classifier under PAMA
* Veracyte Inc - reimbursement rate for Afirma Genomic Classifier is expected to increase from $3,220 to $3,600 for calendar year 2018
- Biotech Forum Daily Digest: What Now For Sarepta?
- Veracyte's (VCYT) CEO Bonnie Anderson on Q3 2017 Results - Earnings Call Transcript
- Veracyte, Inc. 2017 Q3 - Results - Earnings Call Slides
- Your Daily Pharma Scoop: Adamis Upside Potential, J&J's SIMPONI Label Expansion, SGEN's Adcetris Upgrade And PDUFA
- Biotech Forum Daily Digest: Still Gains Ahead For Dynavax?
- Veracyte's (VCYT) CEO Bonnie Anderson on Q2 2017 Results - Earnings Call Transcript